Dr. Anas El Mogharbel, MD

Dr. El Mogharbel practices at BronxCare Ambulatory Care Network in Bronx, New York.

Dr. El Mogharbel's NPI, 1356041453, was assigned on March 7, 2023. Dr. El Mogharbel holds New York license 322053.

Dr. El Mogharbel's primary practice is BronxCare Ambulatory Care Network, at 1650 Grand Concourse FL 14, Bronx, NY 10457 in Bronx County. The practice phone is (718) 518-5000.

Dr. El Mogharbel's primary practice is BronxCare Ambulatory Care Network in Bronx, New York. Dr. El Mogharbel is also affiliated with BronxCare Hospital Center. The medical group on file is BronxCare Health System. Dmand AI also links Dr. El Mogharbel to 1 more breast imaging center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. El Mogharbel practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. El Mogharbel's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. El Mogharbel's licenses on file in 2 states: New York and Ohio.

CMS data shows 125 Medicare services from Dr. El Mogharbel across 3 procedure codes in 2024, all of them office visits, for 78 Medicare patients. Medicare paid $7,874 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 78 Medicare patients who saw Dr. El Mogharbel in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have high blood pressure, and 62% have high cholesterol. 83% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. El Mogharbel's median patient age at 60, with 66% women.

In 2024, Dr. El Mogharbel wrote 460 Medicare Part D claims for 105 patients. 77% of them were for generic drugs. CMS names the drug for 361 of them, across 10 drugs with 11 or more claims each, at $720,902 in total drug cost. In 2023, CMS named 40 claims across 3 drugs.

Dr. El Mogharbel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 45 general payments to Dr. El Mogharbel from 14 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 98% of the total. Astellas Pharma US Inc paid the most, $261.